Talis Biomedical
(NASDAQ) TLIS
Talis Biomedical Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$300.00K
Net Income (TTM)
$51.03M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
TLIS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Talis Biomedical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
99
CEO
Robert J. Kelley, MBA
Website
www.talis.bioHeadquarters
Menlo Park, CA 94025, US
TLIS Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-162%
Net Income Margin
-151%
Return on Equity
-63%
Return on Capital
-78%
Return on Assets
-65%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$371.00K
Operating Income
$66.81M
EBITDA
$66.05M
Operating Cash Flow
$53.24M
Capital Expenditure
$486.00K
Free Cash Flow
$53.73M
Cash & ST Invst.
$76.73M
Total Debt
$19.67M
Talis Biomedical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$84.00K
-304.9%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
99
N/A
Net Income
$8.85M
+41.1%
EBITDA
$9.49M
+41.5%
Quarterly Fundamentals
Net Cash
$41.07M
-47.2%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
-100.0%
Long Term Debt
$15.88M
-10.0%
Short Term Debt
$5.85M
+6.8%
Return on Assets
-65.50%
N/A
Return on Invested Capital
-77.78%
N/A
Free Cash Flow
$11.33M
+23.2%
Operating Cash Flow
$11.33M
+20.6%